Vanguard Fiduciary Trust
LPCN icon

Vanguard Fiduciary Trust’s Lipocine LPCN Stock Holding History

Vanguard Fiduciary Trust’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Buy
54,539
+22,126
+68% +$53.2K ﹤0.01% 3670
2026
Q1 		$259K Buy
+32,413
New +$282K ﹤0.01% 3436

Other funds holding LPCN

SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust's LPCN Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Lipocine (LPCN) stake by 68% in Q2 2026, buying an estimated $53.2K and bringing the position to 54,539 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #3670.

Vanguard Fiduciary Trust first reported a position in LPCN in Q1 2026 and has held it in 2 quarters since. The position peaked at $259K in Q1 2026. 36 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

  • Vanguard Fiduciary Trust held 54,539 shares of Lipocine worth $140K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 22,126 Lipocine shares in Q2 2026, an estimated $53.2K.
  • Lipocine made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3670 holding.
  • Vanguard Fiduciary Trust first reported a position in Lipocine in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Lipocine position peaked at $259K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.